STATE STREET CORP - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 225 filers reported holding BRIDGEBIO PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.6%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$132,915,717
+9.3%
5,040,414
-28.7%
0.01%
+16.7%
Q2 2023$121,592,992
+42.6%
7,069,360
+37.5%
0.01%
+20.0%
Q1 2023$85,271,156
-36.7%
5,143,013
-70.9%
0.01%
+25.0%
Q4 2022$134,796,932
+70.7%
17,689,886
+122.7%
0.00%
-20.0%
Q3 2022$78,952,000
-20.6%
7,942,811
-27.5%
0.01%
-16.7%
Q2 2022$99,490,000
+6.5%
10,957,063
+19.0%
0.01%
+20.0%
Q1 2022$93,443,000
+59.0%
9,206,234
+161.4%
0.01%
+66.7%
Q4 2021$58,755,000
-59.4%
3,522,463
+14.2%
0.00%
-62.5%
Q3 2021$144,540,000
-10.6%
3,083,859
+16.2%
0.01%
-11.1%
Q2 2021$161,757,000
+11.0%
2,653,496
+12.2%
0.01%
+12.5%
Q1 2021$145,707,000
-10.8%
2,365,372
+3.0%
0.01%
-20.0%
Q4 2020$163,306,000
+84.9%
2,296,523
-2.5%
0.01%
+66.7%
Q3 2020$88,341,000
-15.0%
2,354,508
-26.1%
0.01%
-25.0%
Q2 2020$103,906,000
+109.1%
3,186,321
+85.9%
0.01%
+100.0%
Q1 2020$49,698,000
+75.4%
1,713,716
+112.0%
0.00%
+100.0%
Q4 2019$28,329,000
+275.2%
808,243
+129.9%
0.00%
+100.0%
Q3 2019$7,550,000351,6380.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$160,016,45665.94%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$819,077,80528.79%
Cormorant Asset Management, LP 4,662,530$122,950,9167.17%
Frazier Life Sciences Management, L.P. 2,725,949$71,883,2754.77%
Octagon Capital Advisors LP 971,639$25,622,1203.94%
M28 Capital Management LP 121,200$3,196,0443.66%
VIKING GLOBAL INVESTORS LP 25,120,991$662,440,5332.69%
BOONE CAPITAL MANAGEMENT LLC 313,381$8,263,8572.61%
Fernwood Investment Management, LLC 235,620$6,213,2992.23%
SOUTHPORT MANAGEMENT, L.L.C. 15,000$395,5502.15%
View complete list of BRIDGEBIO PHARMA INC shareholders